Qatar Foundation Ushers in New Era of Healthcare With Official Inauguration of Sidra Medicine

Food and Healthcare Press Releases Wednesday November 14, 2018 08:00
DOHA, Qatar--14 Nov--PRNewswire/InfoQuest

Her Highness Sheikha Moza bint Nasser, Chairperson of Qatar Foundation (QF), today officially inaugurated Sidra Medicine - a brand new, world-leading women's and children's hospital in Qatar. The grand opening reflects the country's broader focus and commitment to transforming the provision of healthcare for the national population, as well as regional and international patients.

To view the Multimedia News Release, please click:
https://www.multivu.com/players/uk/8445051-qatar-foundation-inauguration-of-sidra/

One of the most ambitious greenfield hospital developments of its kind, Sidra Medicine represents the vision of Her Highness Sheikha Moza bint Nasser to develop the region's leading academic medical center and provide healthcare of the highest global standards for the people of Qatar and beyond. The high-tech facility is situated in a striking building designed by world-leading architect Cesar Pelli. More than 4,000 highly trained clinical and support staff representing over 95 nationalities have been drawn by the hospital's ambitious vision to care for women, children and young people.

Commenting on the ceremony, Peter Morris, CEO of Sidra Medicine said: "Sidra Medicine's vision is to become a beacon of learning, discovery and exceptional care. Under the leadership of Her Highness Sheikha Moza bint Nasser, we have made incredible progress in a short space of time and laid strong foundations for our future success. At Sidra Medicine we have globally competitive clinicians and scientists working together on a single campus with state-of-the-art equipment and technology in a stunning new hospital."

With access to leading technology ranging from intra-operative MRIs and robotic assisted surgical systems, experts at Sidra Medicine focus on treating a range of highly complex, challenging conditions. Some of the children's specialist services include cardiology, neurology, urology and plastics and craniofacial reconstruction.

The hospital will address the growing need for specialist children's and maternity care by offering services previously unavailable in Qatar, and in many cases across the wider MENA region. It is also pioneering leading biomedical research with the potential to support highly personalized and targeted treatments for specific diseases by collaborating with the Qatar Biobank and the Qatar Genome Programme (QGP). The QGP, a member of QF, is an ambitious population-based project designed to generate genome sequencing and molecular data about the Qatari population and link it to a national electronic medical record system in support of personalized medicine.

Among its many other research priorities, Sidra Medicine focuses on developing detailed epidemiological data to understand the biochemical and molecular diagnosis of childhood diabetes in Qatar. Efforts to build an accurate bank of data showing the causes of diabetes for the entire pediatric population are underway, with the aim to tailor treatment for each child cared for at Sidra Medicine.

Contacts
Farhana Habib
Public Relations
t. +974-4404-2176
m. +974-7478-4648
fcoelho@sidra.org
Photo: https://mma.prnewswire.com/media/781712/Sidra_Medicine.jpg
Video: https://www.multivu.com/players/uk/8445051-qatar-foundation-inauguration-of-sidra/
Source: Sidra Medicine

Latest Press Release

Surgical Specialties Corporation Launches Caliber Ophthalmics Division to Focus on Global Growth of Ophthalmic Surgical Procedures

Surgical Specialties Corporation (SSC) announced today the launch of Caliber Ophthalmics, a new business division. Caliber Ophthalmics combines SSC's Sharpoint(TM) brand, which has earned a trusted reputation serving ophthalmic surgeons for over 50...

After $7.1 Billion Sale Of Frutarom, Ori Yehudai To Join The Sade Group As Active Chairman and Investor

Ori Yehudai: "I took a company worth $3 million and sold it to IFF at $7.1 billion in 2018. In my opinion, the success of our cannabis company will be to build an industrial pharmaceutical company with the strictest standards, we had two such plants, and...

A New Approach to Treating Alzheimer#s Disease Receives Major NIA Backing

T3D Therapeutics to Receive $9 Million Multiyear National Institute on Aging Grant for Phase 2 PIONEER Study in Mild-to-Moderate Alzheimer's Disease Patients T3D Therapeutics, a clinical stage drug development company engaged in the development of...

Welcome to SafeHouse Rehab

SafeHouse Rehab Center Thailand is a private residential treatment facility like no other. From the moment you are collected from the airport until the moment you complete your treatment, we ensure you are safe, secure and your confidentiality is...

Apollo Proton Cancer Centre, Chennai performs India#s First Total Marrow Irradiation Procedure

In a first-ever milestone in cancer treatment in India, the Apollo Proton Cancer Center (APCC) in Chennai has successfully performed Total Marrow Irradiation (TMI) as a conditioning protocol prior to Bone Marrow Transplant. Dr. Preetha Reddy, Vice...

Related Topics